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Aims: With the advances in nanotechnology, pure silver has recently been 
engineered into nanosized particles with diameter less than 100 nm and utilized in 
the treatment of wounds. Together with other studies, we have previously 
demonstrated that topical application of silver nanoparticles (AgNPs) could promote 
wound healing through a modulation of cytokines. Nonetheless, the question of 
whether silver nanoparticles have the potential to affect various skin cell types - 
keratinocytes and fibroblasts, during the process of wound healing still remains. The 
aim of this study was therefore to focus on the cellular response and events of 
dermal contraction and epidermal re-epithelization during wound healing under the 
influence of nanosilver. 
Materials & Methods: We employed a using a full-thickness excisional wound 
model in mice. The wounds were treated with either nanosilver particles or control 
with silver sulphadiazine. The proliferation and biological events of keratinocytes 
and fibroblasts during healing were studied. 
Results: Our results confirmed that silver nanoparticles could increase the rate of 
wound closure. This was achieved, on one hand, through the promotion of 
proliferation and migration of keratinocytes. On the other hand, AgNPs could drive 
the differentiation of fibroblasts into myofibroblasts, thereby promoting wound 
contraction.  
Conclusions: These findings have further extended our current knowledge of silver 
nanoparticles in biological and cellular events and also have significant implications 
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for the treatment of wounds in the clinical setting. 























Healing of wound is a complex and multiple-step process involving integration of 
activities of different tissues and cell lineages.[1] Re-epithelization, a crucial process 
during the early phase of wound healing, occurs not only by the migration and 
proliferation of keratinocytes in the epidermal layer of skin from the wound edge, but 
also by differentiation of stem cells residing in the bulge of hair follicle.[2] Rapid 
re-epithelization after wounding will provide an optimum environment, such as a 
scaffold of cells and various growth factors, which are indispensable in wound 
healing. Further to re-epithelialization, wound contraction is another important 
process in the early phase of wound healing. It minimizes the open area by pulling 
the neighboring tissue towards the wound center. In this process, alpha smooth 
muscle actins (α-SMA), generated from myofibrobalsts, play a vital role in wound 
contraction. Myofibroblasts differentiated from fibroblasts generate the contractile 
force, through which the wound area could contract during wound healing.[3-4] This 
process occurs faster than re-epithelialization because no cell proliferation is 
involved.[5] Thus, intensive research of developing new drugs and technologies, are 
being currently pursued, for the promotion of re-epithelization and wound 
contraction. 
Although silver nitrate was used as a disinfecting agent for wounds as far back as 
World War I, the current use of silver agents has been reduced to topical silver 
sulfadiazine cream in the treatment of burn wounds because of the availability of 
excellent and effective antibiotics.[6-11] Renewed interest in silver only rekindled after 
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nanotechnology has made it possible to produce pure silver particles in the 
nano-scale. In the case of exposing cells or tissue to silver nanoparticles (AgNPs), 
the active surface would be significantly larger compared to silver compounds, and 
thereby exhibiting remarkably unusual physicochemical properties and biological 
activities.  
In our previous work using a burn wound model in mice, we demonstrated that 
silver nanoparticles promoted wound healing through its powerful antibacterial 
property, as well as its ability to reduce inflammation.[12-13] Nonetheless, the 
observed findings were only the end result of the complex interplay between various 
resident skin cell types and the recruited inflammatory cells. The question thus 
remains on whether silver nanoparticles can have individual effects on various the 
skin cell types. This is particularly important in the wound healing process since 
re-epithelization and wound contraction represent two components mediated by two 
different cell types – keratinocytes and fibroblasts. In this study, we chose an 
excisional wound model because this model provided a relatively cleaner wound 
than the burn wound and therefore could reduce the potential effect of the infective 
factor. Furthermore, we could separate and observe more clearly the cellular events 
occurring in keratinocytes and fibroblasts during wound healing. Our results showed 
that silver nanoparticles could indeed mediate different events in keratinocytes and 
fibroblasts. On the one hand, there was an increase in the rate of proliferation of 
keratinocytes after wounding. In contrast, proliferation of fibroblasts was suppressed, 
but with subsequent drive towards differentiation into myofibroblasts. The findings 
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have further improved our existing knowledge in the action of silver nanoparticles 
on a cellular level and we also showed for the first time that this precious metal 
could have differential effects on different cell types.  
 
MATERIALS AND METHODS 
Animals    
C57BL/6N aged between 6-8 weeks old, weighing between 16-22 grams were 
obtained from the Laboratory Animal Unit, The University of Hong Kong. The 
animals were allowed diet and water ad libitum in a 12-hour light, 12-hour dark 
cycled room. The experimental protocol was approved by the Committee of the Use 
of Live Animals in Teaching and Research, The University of Hong Kong 
(CULATR 1599-08). Anesthesia for experimentation was achieved with an 
intra-peritoneal injection of pentobarbital sodium solution (Abbott Laboratories, 
U.S.A) at a dose of 50 mg/Kg. 
 
Nanosilver particles and other silver preparations    
Nanosilver particles (AgNPs) were synthesized based on the following method. 10 
mg of sodium borohydride was added into a 0.1 mM silver nitrate solution (1L), 
which contained 0.7 mM of sodium citrate, and the solution was stirred overnight. 
The reaction was monitored by UV-vis spectroscopy until no further absorption 
increase at 400 nm wavelengths. The solution was then reduced to 100ml by rotary 
evaporator. Final concentration of solution was 1 mM. The mean diameter of the 
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nanosilver particles was 10 nm (range 5 to 15nm) and confirmed by electron 
microscopy.  
1% silver sulphadiazine (SSD) cream (Smith & Nephew Phamacenticals Ltd., USA) 
was used as control in animal experiments (silver content 3.02 mg/g). In in-vitro 
experiments, silver sulphadiazine powder (C10H9AgN4O2S; FW 357.14, 98%) was 
purchased from Sigma-Aldrich. The powder was added and dissolved thoroughly in 
sterile water to make a final concentration of 1 mM.  
 
Wounding Protocol and Treatment  
Mice were randomly divided into three groups, AgNPs group, SSD group and no 
treatment group (n=5). After anesthesia, the dorsal hair was shaved and cleansed 
with 10% w/V povidone iodine before a 1.5×1.5 cm2 full-thickness wound was 
created surgically. In the AgNPs group, AgNPs solution coated dressing was 
topically applied to the wound bed, with the AgNPs concentration in each dressing 
equal to previously described (0.04 mg/cm2).[13] In the SSD group, mice were 
treated by topical application of 30 mg 1% silver sulphadiazine cream, the same 
amount of silver as those in the AgNPs group. The wound dressings were changed 
daily until sacrifice or wound healing. 
 
Morphometric assessment of wound re-epithelization and wound closure 
Morphometric assessment of wound re-epithelization and wound closure was 
examined and documented daily using digital photography. The digital camera was 
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secured on a cantilever at a fixed distance. Wound areas (cm2) were calculated from 
wound perimeter tracings using Photoshop CS (Adobe, USA) in a single-blinded 
manner until the wound was completely healed. The healing rate was expressed as a 
percentage of the original dorsal wound area on day 0 after wounding (1.5x1.5cm2). 
Thus:    
                             Wound area on day n 
% Wound area   =                                           × 100%  
                          Original wound area at day 0 
 
Histological Examination  
At various time points, mice from each group were sacrificed and the original 
wound areas were harvested, formalin-fixed and embedded in paraffin. 5 µm 
sections were microtomed, de-waxed and re-hydrated. Staining was performed with 
hematoxylin and eosin (H&E). In order to observe the extent of re-epithelization 
(migration of keratinocytes in nascent epidermal layer of skin), the harvested wound 
tissues were sectioned through the centre of the wounds, thereby incorporating areas 
from the centre to the original wound edge. Four photographs (40x) were taken and 
cells were counted, with the final data expressed from an average of four sections. 
 
Cell culture  
For in-vitro cell culture, mouse embryo fibroblast cell line (BALB/3T3; clone A31) 
was purchased from ATCC and was cultured as described. Briefly, fibroblasts were 
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seeded and grown in DMEM (Sigma, USA) with 10% FBS and 
penicillin/streptomycin mixture in 5% CO2 at 37°C. The cultures were passaged 
twice before experiments.  
Ex-vivo culture of keratinocytes and fibroblasts were obtained from the dorsal skins 
of mice after sacrifice. The skin was cleansed with 10% w/V povidone iodine and 
washed in the D-hanks solution 5 times and the subcutaneous tissues were removed. 
Each piece of skin (5cm x 5cm) was then cut into 0.5cm x 0.5cm fragments. 0.25 % 
dispase II (Sigma) was added to cover the skin fragments and left to digest at 4°C for 
16 hours. The epidermis was peeled off for keratinocyte culture. The dermis tissue 
was put into a fresh dish for fibroblast culture. The epidermal tissues harvested were 
cultured in 8-well plates using epidermal keratinocyte medium with 10% fetal 
bovine serum. Dermal tissues harvested were cultured in 8-well plates using DMEM 
containing 10% fetal bovine serum. 100µl of AgNPs solution (50 µM) was added to 
wells, with SSD as the control. In each well, 10 random visual fields (100x) were 
chosen to calculate the outgrowth cell number. 
 
Immunohistochemistry (IHC) and fluorescence staining 
Healing wound tissues were harvested and processed as previously. The endogenous 
peroxidase was quenched by treated in 3% hydrogen peroxide/methanol for 10 min. 
Sections were incubated for 1 hour at room temperature with blocking solution 
containing 5% normal goat serum (Dako Bioresearch, USA). For antigen retrieval of 
alpha-SMA staining, the sections were further blocked for nonspecific binding with 
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10% normal goat serum before primary antibody (anti-α-SMA, Abcam Ltd, USA) 
(1:100) was added. The sections were incubated overnight at 4°C before rinsing in 
PBS, and then incubated with HRP-conjugated secondary antibody (Santa Cruz, 
USA) for 1 hour. Positive signals were developed using DAB (3,3’-diaminobenzide 
tetrahydrochloride) and counterstained with hematoxylin. FITC-conjugated goat 
anti-mouse antibody was used as the secondary antibody for PCNA (PC10, Santa 
Cruz, USA) (1:200) for fluorescence staining. The tissues were washed three times 
in 1x PBS and stained with DAPI prior to microscopy.  
For immunostaining of type I collagen and α-SMA in cell culture, fibroblasts grown 
in chambers and mounted on glass slide with cover. AgNPs or SSD was added to the 
medium to make concentration of 50 µM. The cells were incubated for 48 hours and 
fixed in 4% paraformaldehyde. Samples were then washed with 0.25% Trion X-100 
(Sigma). 1% BSA was used to block non-specific binding before the addition of 
anti-α-SMA antibody (Abcam Ltd, USA) (1:100) or anti-type I collagen antibody 
(Abcam Ltd, USA) (1:100). TRITC-conjugated goat anti-mouse antibody (1:200) 
and TRITC-conjugated goat anti-rabbit antibody (1:200) were respectively used as 
the secondary antibody. The samples were washed three times and incubated on 
DAPI for 1 minute. Images were viewed under microscopy. 
 
Hydroxyproline (Hyp) detection 
For the determination of the hydroxyproline concentration, Medugorac’s method was 
performed.[14] The collagen content in supernatant was estimated from the 
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hydroproxyline concentration by multiplying its value by 7.46. Hydroxyproline (Hyp) 
kit was purchased from JianChen Gene Company (Nanjing, PR China) to detect the 
production of Hyp and content of collagen in supernatant. 0.875 x105 cells were 
seeded in 1 ml DMEM (Sigma, USA) with 10% FBS and penicillin/streptomycin 
mixture on each well of 6 well-plate in 5% CO2 at 37°C and incubated for 24 hours. 
Treatment with various concentrations of silver nanoparticles was added and then 
incubated for 2 days. Supernatant in each well was collected and made in triplicates 
for test tubes. 250µl of supernatant and 50µl digestive solution were added to the test 
tubes and incubated for 3 hours in 37°C warm bath. Then, 500µl of isopropanol, 
500µl of oxidant of solution, 1 ml of 7% trihydrated chloramine-T solution were 
added. These were mixed well and incubated for 15 minutes at 60°C. The tubes were 
centrifuged at 3500rpm for 10 minutes at room temperature. The absorbance in each 
tube was measured at 550 nm in a microtiter plate reader (Bio-Rad Inc, USA). The 
average values from triplicate readings were calculated.  
                    
MTT assay 
Cell proliferation assay kit (Roche, Germany) was used to measure cell proliferation 
rate and reduction in cell viability during apoptosis or necrosis. 2x103 cells were 
plated out, in triplicate, into wells of a microtiter plate. Three control wells with 
medium alone were used to provide blanks for absorbance readings. Treatment with 
various concentrations of silver nanoparticles was added, followed by 100 µL of MTT 
Reagent to each well, including controls. When purple precipitate was clearly visible 
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under the microscope, 100 µL of Detergent Reagent was added to all wells, including 
control. The plate was covered and left in the dark for overnight in 37°C incubator. 
The plate cover was removed and the absorbance in each well was measured at 570 
nm in a microtiter plate reader (Bio-Rad Inc, USA). The average values from 




Statistical analyses were performed using Student’s paired t-test. A p value of < 0.05 
was considered significant. 
 
Results 
Accelerated wound closure by silver nanoparticles in early phase of wound healing  
The earliest histological change in the wound bed after wounding is wound 
contraction. This is a vital process to minimize open wound area. Wound contraction 
is effected through activated fibroblasts located on the wound edge. These 
differentiate into the myofibroblasts, which will secret actins and elastic fibers for 
wound contraction. In order to assess the wound-contraction rate, we measured the 
percentage of wound bed area at various time points until complete wound closure. 
In our model, untreated wounds closed after 28.1±1.60 days. In mice treated with 
silver nanoparticles, this event took only 18.4±1.26 days, while wounds closed in 
24±0.67 days in animals treated with silver sulphadiazine (p?0.01) (Figures 1 
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A&B).  
We next calculated the rate of wound closure using the formula described previously. 
As can be seen in Figure 1C, the rate of wound closure in the AgNPs group from 
day 9 post wounding significantly increased when compared with control (p<0.01), 
with the wound area decreased to 31.23% of original size as early as day 12 and to 
3.34% on day15. These observations further confirmed that silver nanoparticles 
could accelerate the wound closure.  
 
Silver nanoparticles promote re-epithelization through increased keratinocyte 
migration and proliferation 
After wounding, although the myofibroblasts (differentiated from fibroblasts) and 
the extracellular matrix provide the necessary environment for wound contraction, it 
is the proliferation and migration of keratinocytes from the wound edge that provide 
cells for wound covering through re-epithelization (Figure 2A). We therefore asked 
whether silver nanoparticles could exert their effects on the proliferation of 
keratinocytes, and thus re-epithelization. First, histological sections taken from day 
7 wounds were studied. Although H&E staining showed that the epithelium at the 
wound edge of all wounds migrated towards the centre, the epithelial tongue 
(indicated by the vertical line) in AgNPs group was found to move faster than 
controls (Figure 2B). The same phenomenon was observed when the extent of 
growth of the epithelial tongues was measured at three different time points (Figure 
2C)  (p?0.01). Using immunohistochemistry to stain for cell divisions in epithelial 
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tongue area, we further confirmed that there was an increase in cell proliferation in 
animals treated with AgNPs (Figure 2D). The average number of proliferating 
keratinocytes in each group obtained by counting in five random visual fields under 
the microscope also showed significantly more proliferating keratinocytes in the 
AgNPs group than in the other two groups (Figure 2E) (p?0.01). Histological 
examination performed on the healed wounds showed also that AgNPs group 
showed the closest resemblance to normal skin (Figure 2F).  
Taken these findings together, although we found a higher density of proliferating 
cells in the epidermal layer in the AgNPs group during the healing phase, the fact 
that the overall histology of the healed skin resembled that of normal epithelium 
would suggest that silver nanoparticles could trigger the maturation of the 
proliferating keratinocytes.  
 
Enhanced keratinocyte outgrowth and inhibited fibroblast proliferation by silver 
nanoparticles 
In order to further understand the possible individual action of silver nanoparticles 
on various skin cell types separately, keratinocytes and fibroblasts were isolated, and 
cultured ex-vivo. After the addition of AgNPs to the culture medium, we found a 
significant increase in keratinocyte proliferation when compared to control (Figure 
3A). Furthermore, this effect appeared to sustain for up to 7 days (Figure 3B).  
In contrast, when fibroblasts were cultured ex-vivo, there was a reduction in the cell 
number in the presence of AgNPs (Figures 3 C&D) (p?0.01).  
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To determine if the reduction in fibroblast number was due to toxicity of AgNPs, 
MTT assay was performed. Our results here demonstrated that at 100µM or less, 
AgNPs was relatively non-toxic to fibroblasts (Figure 4A). Furthermore, when we 
determined the level of production of hydroxyproline and collagen in fibroblasts, we 
showed that silver nanoparticles could significantly decrease the production of these 
proteins in the supernatant (Figure 4B-D). This would suggest that the addition of 
silver nanoparticles could change the normal phenotype of the fibroblasts. 
 
Differentiation of myofibroblasts from fibroblast driven by silver nanoparticles   
When one looks more closely at the events duing wound healing, wound contraction 
certainly plays a significant role. We therefore asked whether the effects of silver 
nanoparticles on fibroblasts could be due to the differentiation of fibroblasts into 
myofibroblasts, with a consequent decrease in cell proliferation.  
Here, we stained cultured fibroblast for collagen I and α-SMA after the addition of 
sivler nanoparticles. As shown in figure 5A, there was a marked reduction of 
collagen I expression. On the other hand, the expression of α-SMA was markedly 
increased (Figure 5B). Taken together, it would suggest a change in phenotype from 
fibroblasts to myobibroblasts.  
To further confirm this finding in vivo, we next took wound sections from our 
experimental animal groups and stained for α-SMA, a marker for myofibrobalsts. 
Normally, α-SMA could only be detected in small amount in normal skin. Here, the 
amount of α-SMA in day 7 wounds in the AgNPs group was significant more when 
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compared to the control groups. (Figure 5C). Thus, it would appear that silver 
nanoparticles could indeed drive the differentiation of resident fibroblasts into 
myofibroblasts in the early phase of wound healing, thereby help to accelerate 
wound bed contraction.  
 
Discussion 
The antibacterial action of silver has been known since ancient times. As a result, 
this precious metal has long been utilized to treat infectious diseases. Despite this, 
only recently have researchers been beginning to unravel some of the mechanisms 
of action of silver. It exerts its antibacterial property by interfering with the 
respiratory chain of the cytochromes and components of the microbial electron 
transportation system, and also binds and inhibits bacteria DNA replication.[15-17] 
Others have found that silver nanoparticles had anti-bacterial and anti-inflammatory 
properties in infectious wound.[18] Nevertheless, the mechanism of action of silver 
on wound healing remains unresolved. In our previous study, we showed that 
topically delivered silver nanoparticles promoted wound healing in a burn wound 
model through their effective antibacterial properties. Furthermore, it appeared that 
silver could modulate cytokine production.[12] In the burn model, it was relatively 
difficult to observe the re-epithelization process and other effects exerted by silver 
on a cellular level during wound healing because of cellular destruction from the 
burn injury. To further clarify and dissect out any possible effects of silver 
nanoparticles on various cell types, we adopted a surgical wound on dorsal skin in 
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mouse. The clean and infection free wound would make it possible to observe the 
morphological change during re-epithelization and wound contraction.  
In this study, we found that, as in the burn wound model, animals treated with silver 
nanoparticles had significantly faster wound closure when compared to the silver 
sulphadiazine group. This result further confirmed the beneficial effects of silver 
nanoparticles, as a treatment for skin wounds. Furthermore, our results would 
suggest that silver in the nano form was a more effective drug than silver 
compounds for wound healing treatment, even when infectious and inflammatory 
factors were eliminated. Our previous study already showed that the addition of 
silver nanoparticles to the wound would reduce both local, as well as systemic 
inflammation, and resulted in faster healing. However, the effect of nanosilver on 
various skin cell types at a biological level is yet unclear. As wound healing involves 
re-epithelization process and wound contraction, it would be prudent to study any 
possible effects of nanosilver on individual cell types. Re-epithelization is a 
complex and multistep process, which involves keratinocyte migration and 
proliferation in the epidermal layer.[5, 19-20] In addition, wound contraction, a cellular 
event which occurs in the dermal layer through myofibrobalsts, minimizes the open 
wound bed by pulling the neighboring tissue towards the wound center. A few 
studies looking into wound healing events have shown that many drugs could 
promote wound healing by accelerated re-epithelization via enhanced keratinocyte 
migration and proliferation.[21-24] In our study, we firstly focused on the 
keratinocytes to investigate the morphological change mediated by silver 
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nanoparticles. In agreement with others, our histological finding demonstrated that 
silver nanoparticles indeed promoted proliferation and migration of keratinocytes 
from wound edge towards the wound center. This was further confirmed in our 
ex-vivo wound model experiment, using keratinocytes from peeled fresh epidermis.  
Apart from faster healing, we also observed from histological evaluation that the 
healed wounds of animals in the silver nanoparticles group resembled closely to 
normal skin, with relatively thin epidermis and normal hair follicles. Taken together, 
it would suggest that silver nanoparticles could trigger the differentiation and 
maturation of keratinocytes, although at this point, the underlying mechanism 
through which silver operates is still unclear. One possibility may be the Notch 
signaling pathway, which is one of the most conserved and commonly used 
communication channels in animal cells. Studies have demonstrated this pathway is 
indispensable for cells in various stages of maturation, including terminal 
differentiation of keratinocytes.[25-26] As a result, further studies are currently 
underway to ascertain if silver does interact with Notch or its ligands. Indeed, as 
keratinocytes arise from the epidermal stem cells, there is also a possibility that 
silver nanoparticles can promote the differentiation and maturation of keratinocytes 
through the stimulation of skin stem cell.[27-30] This is an important issue because the 
ability to manipulate stem cells would open a new dimension in terms of tissue 
regeneration in the future.  
On the other hand, although fibroblasts have been targets of intense research in the 
formation of keloid and hypertrophic scars, their role in the process of wound 
 19 
healing has largely been neglected.[31-38] In our study, we also focused on the 
fibroblasts in the dermal layer. As our ex-vivo experiments clearly showed, in 
contrast to the effects seen in keratinocytes, the addition of silver nanoparticles 
suppressed the proliferation of fibroblasts. For this finding, we further confirmed that 
the suppression was not due to the toxic effects of silver. Looking back at the results 
on keratinocytes, it would appear that silver nanoparticles could drive differentiation 
and maturation. We therefore asked if the same effect could be seen in fibroblasts. 
Indeed, the decreased level of collagen in fibroblasts treated with nanosilver already 
would suggest that this could be the case. This was further confirmed by the 
increased expression of α-SMA, a marker of myofibroblast, both in in-vitro, as well 
as in-vivo experiments. This would suggest, as in the case of keratinocytes, that 
silver nanoparticles could indeed stimulate cell maturation, and hence, driving 
fibroblasts into myofibrobalsts during healing. Taken all the evidence taken together, 
we can now explain, at least at the cellular level, the reason why silver nanoparticles 
could significantly promote wound healing. It would seem that both wound 
re-epithelializaion and contraction are increased through the differential effects of 
silver on keratinocytes and fibroblasts. Despite this, how silver interacts at the 
molecular level during wound healing still remains to be determined. Microarray 
analyses are currently ongoing in our laboratory to try to unravel this mystery and 
identify the signaling pathways involved.  
In addition to the beneficial effects on wound healing, the reduction of collagen 
production in fibroblasts by silver nanoparticles may suggest a role in anti-fibrosis 
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therapy, which could be useful in preventing and perhaps treating keloids and scars. 
If indeed this were to be the case, silver nanoparticles could prove to be the Holy 
Grail for wound healing without scars. In conclusion, our study further confirmed the 
significantly beneficial effects of silver nanoparticles on wound healing and for the 
first time, provided the evidence that silver could act on keratinocytes and fibroblasts. 
This has further enhanced our knowledge of the biological events exerted by this 
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Figure legends 
Figure 1 – The effects of silver nanoparticles on wound healing.  Excisional 
skin wounds were created on the dorsum of mice and they were divided in 3 groups 
(n=5) and received nanosilver particles, silver sulphadiazine or no treatment 
respectively. The wounds were inspected daily and the rate of healing was recorded. 
A. The time to complete wound closure in each group. (** p<0.01; *** p< 0.001) B. 
Photographs of wound appearance from three groups at various time points. C. The 
rate of wound closure at various time points after wounding.  
 
Figure 2 - Re-epithelization and proliferation of keratinocytes mediated by the 
silver nanoparticles during healing.  
A. Schematic drawing of a wound indicating the location of proliferating cells 
examined. Region 1 represents the re-epithelization area and region 2 represents the 
epithelial tongue. B. The wounds were excised and stained with H&E on day 7 after 
wounding and the degree of wound closure was examined histologically. 
Proliferating cells arising form wound edge on the left migrated towards to the 
wound centre on the right. The blue bar indicates the leading edge of the epithelium. 
C. The extent of re-epithelization on day 7, day 10, and day 15 after wounding was 
measured histologically in three groups and represented (* p<0.05, ** p<0.01). D. 
immunohistochemistry staining of proliferating cells in the epithelial tongue area on 
day 15 after wounding. Dash line indicates the divison between the epithelial layer 
and the dermal layer. Scale bar: 20 um. E. Average numbers of proliferating cells in 
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epithelial tongue area on day 15 sample after wounding  (** p<0.01; *** P< 0.001) 
F. Histological morphology of healed wounds in animals from the three groups.  
 
Figure 3 - The effects of AgNPs on keratinocytes and fibroblasts in culture.  
Keratinocytes and fibroblasts were obtained from the dorsal skins of mice, digested 
with 0.25 % dispase II, and cultured in appropriate media with either AgNPs or SSD. 
The number of cells in the outgrowth area was counted in each well and averaged. 
A. The number of keratinocytes growing out from the epidermal margin in three 
groups after 2 days culturing (Scale: 100 um). B. Keratinocyte numbers in the 
outgrowth area counted and averaged at 6 time points. C. The number of fibroblasts 
grown from the dermal margin in three groups after 2 days culturing (Scale: 100 
um). D. Fibroblast numbers in the outgrowth area at 6 time points.  
 
Figure 4 – The effects of AgNPs on fibroblasts apoptosis and protein 
production.  
Mouse embryo fibroblast cell line (BALB/3T3; clone A31) was cultured in medium 
with the addition of AgNPs for 24 hours and the effects on cell death and protein 
(collagen and hydroxyproline) were studied.  
A. Viability of BALB/3T3 cells treated with AgNPs at a concentration range from 10 
to 400 uM is expressed as percentage of untreated cells. Values are the mean±SE. (** 
p<0.01) B. Hyp content in supernatants of BALB/3T3 cells under different AgNPs 
concentration after 24 hours culture. The concentration was measured using 
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absorbance readings. C. Collagen content of BALB/3T3 cells in different AgNPs 
concentrations. 
 
Figure 5 - Stimulated differentiatiation of fibroblast into myofibroblasts 
mediated by silver nanoparticles.  
A. 3T3 fibroblasts cell line was cultured and treated with SSD and AgNPs and  the 
level of collagen I was measured using immunohistochemistry.  
B. Staining for myofibroblasts using α-SMA after culturing 3T3 fibrobalsts with 
AgNPs or SSD for 48 hours. (Red: α-SMA; Blue: nuclear of fibroblasts; Scale bar: 
40 um).  
C. α-SMA staining on Day 7 wounds of animals treated with either AgNPs or SSD 
and a comparison to normal skin. (Scale bar (left): 40 um. Scale bar (right): 20 um)  
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